Viewing StudyNCT05891548



Ignite Creation Date: 2024-05-06 @ 7:05 PM
Last Modification Date: 2024-10-26 @ 3:00 PM
Study NCT ID: NCT05891548
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-11-02
First Post: 2023-05-24

Brief Title: Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
Sponsor: Clearside Biomedical Inc
Organization: Clearside Biomedical Inc

Conditions & Keywords Data

Conditions:
Name
Neovascular Age-related Macular Degeneration
Keywords:
Name View
Suprachoroidal Space SCS View
AMD View
Wet AMD View
Suprachoroidal View
Tyrosine kinase inhibitor View
Microinjector View